17 November 2016 – SYDNEY
Nearmap Ltd (ASX:NEA) confirms that shareholder approval will be sought at the Company’s annual general meeting today for the grant of 2,000,000 Director Options to CEO Dr Rob Newman (or his nominee), at an exercise price that is 43% above the closing share price of the Company’s quoted Shares on ASX the trading day prior to the annual general meeting.
The exercise price for the options proposed to be issued to Dr Newman, based on yesterday’s closing share price of $0.74, is $1.06.
Full terms and conditions of the options are disclosed in the Notice of Meeting that was despatched to shareholders on 18 October 2016. The Company will advise the outcome of the meeting in due course.
For further information please download PDF attached:
Download this document
